NCT00682370View on ClinicalTrials.gov

Effects of Heme Arginate in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Healthy SubjectsHeme OxygenaseGenetic Polymorphism
Interventions
DRUG

saline solution

intravenous infusion, single dose

DRUG

heme arginate

"intravenous infusion, single dose~0.3 mg/kg heme arginate"

DRUG

heme arginate

"intravenous infusion, single dose~1 mg/kg heme arginate"

DRUG

heme arginate

"intravenous infusion, single dose~3 mg/kg heme arginate"

Trial Locations (1)

1090

Medical University of Vienna, Vienna

All Listed Sponsors
lead

Daniel Doberer

OTHER

NCT00682370 - Effects of Heme Arginate in Healthy Male Subjects | Biotech Hunter | Biotech Hunter